Miromatrix Awarded $1.9 Million NIH Grant to Advance the Development of a Bioengineered Liver View more
FDA Approves EVENITY™ (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture View more
Medical Alley Powering the Evolution of Healthcare with More Than $2.8 Billion Invested and $2 Billion in Exits View more